News

According to the third Real-World Evidence (RWE) benchmarking survey published in June 2022 by Deloitte, there is a segmentation of outcomes between businesses with more developed organisational and technological RWE capabilities and those with less developed skills. Since Deloitte's latest...

The Paris-based pharmaceutical company is setting up a fund to assist companies who want to provide healthcare solutions in neglected areas. The objective is to assist in the establishment of locally resilient organisations. According to Jon Fairest of Sanofi, innovation...

The oral, once-daily Zejula (niraparib) tablet, a first-line and recurrent upkeep care for women with advanced epithelial high-grade ovarian, fallopian tube, or primary peritoneal cancer who are in full or partial remission after platinum-based chemotherapy, has been approved by...

The NHS has used its purchasing power to negotiate lower rates for dozens of hospital medications, saving taxpayers £1.2 billion in only three years while obtaining cutting-edge therapies for patients. One third of the savings have been attributable to the...

Abbott informed yesterday, July 3rd, that there are several ways to tell if a customer's pack of Thyronorm is authentic or fake. The label of the product has a QR code that, when scanned, opens a homepage with a...

Recent market analysis predicts that the international market for biopharmaceutical bioseparation systems, which is expected to be worth $13 billion in 2022, will increase to $19.6 billion by 2026, growing at a 13.2% compound annual growth rate (CAGR). According to the...

The Vaccines and Related Biological Products Advisory Panel of the U.S. Food and Drug Administration gathered on June 30th to evaluate whether a change to the COVID-19 vaccine strain composition for booster doses for the fall and winter seasons of...